ORPH NASDAQ
Orphazyme A/S
1W: -2.5%
1M: -29.3%
3M: -65.3%
1Y: -89.6%
$0.87
Last traded 2022-03-30 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$20K
+100.0% ▲
Capital Expenditures
$0
+100.0% ▲
Free Cash Flow
-$20K
+100.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$3M
+0.0% ▲
Net Change in Cash
-$28K
+0.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$336M | -$633M | -$627M | -$38M | -$26K |
| Depreciation & Amort. | $4M | $5M | $18M | $782K | $0 |
| Stock-Based Comp. | $3K | $28K | $16M | $0 | $126 |
| Change in Working Capital | $2M | $48M | -$932K | -$3M | $11K |
| Other Non-Cash Items | $1K | $15M | -$4M | -$64M | -$5K |
| Operating Cash Flow | -$327M | -$539M | -$603M | -$105M | -$20K |
| — Investing Activities — | |||||
| Capital Expenditures | -$3M | -$5M | -$994K | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $1M | $1M | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | -$7M |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$508 | -$3K | $138 | $89M | -$7K |
| Investing Cash Flow | -$3M | -$5M | $46K | $90M | -$7K |
| — Financing Activities — | |||||
| Net Debt Issuance | $59M | -$11M | -$29M | -$39M | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | -$3M |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | -$111M | -$2M | -$1M | $684K |
| Financing Cash Flow | $59M | $1.2B | -$30M | -$35M | -$685 |
| Net Change in Cash | -$271M | $603M | -$625M | $0 | -$28K |
| Cash End of Period | $124M | $727M | $102M | $39M | $11K |
| Free Cash Flow | -$330M | -$544M | -$604M | -$118M | -$20K |